Contineum Therapeutics, Inc. Class A Common Stock

CTNM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$42,633$20,784$22,470$21,943
Short-Term Investments$139,774$154,700$168,240$182,817
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,520$1,355$1,424$1,628
Total Curr. Assets$184,927$176,839$192,134$206,388
Property Plant & Equip (Net)$5,654$5,863$6,126$6,456
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$266$186$4$3
Total NC Assets$5,920$6,049$6,130$6,459
Other Assets$0$0$0$0
Total Assets$190,847$182,888$198,264$212,847
Liabilities
Payables$786$2,001$3,645$1,811
Short-Term Debt$1,477$1,466$1,455$1,452
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,098$3,747$3,849$6,746
Total Curr. Liab.$6,361$7,214$8,949$9,974
LT Debt$4,016$4,284$4,547$4,807
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$4,016$4,284$4,547$4,807
Other Liabilities$0$0$0$0
Cap. Leases$0$5,750$6,002$6,259
Total Liabilities$10,377$11,498$13,496$14,781
Equity
Pref Stock$0$0$0$0
Common Stock$29$26$26$26
Retained Earnings-$162,224-$149,432-$133,392-$117,402
AOCI$265$147$170$71
Other Equity$342,400$320,649$317,964$315,371
Total Equity$180,470$171,390$184,768$198,066
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$190,847$182,888$198,264$212,847
Net Debt-$37,140-$15,034-$16,468-$15,684
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial Statements & Key Stats | AlphaPilot